You are here: Industry Insights > COVID-19 Vaccines

News List

PM: Cambodians to receive AstraZeneca 3rd dose as 'booster' firstwordpharma
August 02, 2021
Cambodia prime minister Hun Sen said that the country will implement booster doses with COVID-19 vaccines, beginning with frontline workers, Khmer Times reported Sunday.
Pfizer and Moderna raise prices for its COVID-19 vaccines in EU firstwordpharma
August 02, 2021
According to the Financial Times, Pfizer and Moderna have raised the prices of their COVID-19 vaccines in their latest supply contracts with the EU, as reported Sunday in Investing.com.
Vaxzevria has similar safety profile to mRNA COVID-19 vaccines, finds study europeanpharmaceuticalreview
July 29, 2021
New studies show rates of blood clots were similar following vaccination with Vaxzevria and Comirnaty®, plus rates of rare blood clots are lower after the second Vaxzevria dose.
Dyadic and Rubic to develop Covid-19 vaccines for African markets pharmaceutical-technology
July 28, 2021
Dyadic International has entered a Covid-19 vaccine technology transfer and licensing agreement with South Africa-based company, Rubic Consortium, to discover, develop, analyse and produce cost-efficient vaccines for supply mainly to the African markets.
Catalent plans $100 million biologics manufacturing expansion at Anagni cphi-online
July 22, 2021
Two 2,000-liter single-use bioreactors to be installed as part of first phase expected to be operational in April 2023
PHE study finds COVID-19 vaccines ‘highly effective’ in at-risk groups pharmatimes
July 13, 2021
A new study from Public Health England (PHE) has found COVID-19 vaccine are as effective at preventing symptomatic disease in most people in clinical risk groups as the rest of the population.
Regulatory issues cause delay in COVID-19 supplies to India from US expresspharma
July 09, 2021
Last month, the US pledged to ship 80 million doses of American made COVID-19 vaccines to countries around the world and India could get one to two million doses of the vaccines.
Aspen to get up to $713m to produce Covid-19 vaccines for African nations pharmaceutical-technology
July 02, 2021
Aspen Pharmacare is set to receive a long-term funding package of nearly $713m (€600m) to boost the production of Coivd-19 vaccines for countries in the African continent.
COVID-19 vaccines have prevented 7.2 million infections and 27,000 deaths in England alone worldpharmanews
June 29, 2021
Latest modelling analysis from Public Health England (PHE) and the University of Cambridge’s MRC Biostatistics Unit suggests that the coronavirus (COVID-19) vaccination programme has so far prevented an estimated 7.2 million infections and ...
COVID-19 vaccines highly effective against hospitalisation by Delta variant europeanpharmaceuticalreview
June 22, 2021
An analysis shows Comirnaty® and the COVID-19 Vaccine AstraZeneca are both over 90 percent effective in preventing hospitalisation from the Delta variant.

Previous page 1 2 3 4 5 Next page